ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


 News | News By Subject | News By Date | Search News
Get Our Industry eNewsletter FREE email:    
 News By Date

SuMoTuWeThFrSa
22232425262728
1234567
891011121314
15161718192021
22232425262728
2930311234

 Tuesday, March 31, 2015
 Top Breaking News
 Featured Stories
New Study Recommends Early Introduction Of Peanuts To Prevent Allergies, Loyola University Health System Reveals
Saccharin Shows Promise As Cancer Inhibitor, University of Florida Researchers Find
Pesticides On Fruits, Veggies Linked With Poorer Semen Quality
New Genetic Link Found For Alcohol-Related Liver Cirrhosis, University of Cincinnati Study
Short Bouts Of High-Intensity Exercise Before A Fatty Meal Best For Promoting Vascular Health In Youth, University of Exeter Study
New Liver Cancer Report, New Links Emerge: Coffee Is Protective, Obesity Increases Risk, World Cancer Research Fund International Reveals
Smartphone Use Changing Our Brain And Thumb Interaction, Say University of Zurich Researchers
Ozone Air Pollution Could Harm Women's Fertility, Pennsylvania State University College Of Medicine Study
 More News
VIVUS, Inc. (VVUS) Updates On Qsymia Plans; Will Continue Talks With U.S., EU Regulators
Ferring Pharmaceuticals Receives FDA Approval For Growth Hormone Name Change, Acquires ZOMACTON [Somatropin (rDNA Origin)] For Injection And Needle-Free Device In The U.S.
Novartis Pharmaceutical Corporation (NVS) Announces FDA Approval For Jadenu To Simplify Treatment Administration For Patients With Chronic Iron Overload
Antares Pharma, Inc. (ATRS) Announces FDA Approval Of TEV-TROPIN(R) 10 Mg (Human Growth Hormone) Needle-Free Injector
Avedro, Inc. Announces Receipt Of Complete Response Letter From FDA For Corneal Cross-Linking NDA
Protalex, Inc. (PRTX) Announces FDA Acceptance Of Investigational New Drug Application For PRTX-100 To Treat Immune Thrombocytopenia
Emmaus Life Sciences To Present Phase 3 Sickle Cell Disease Clinical Trial Data
PAION AG Announces Initiation Of U.S. Phase 3 Clinical Trial Of Remimazolam For Procedural Sedation During Colonoscopy
GW Pharmaceuticals (GWPH) Initiates First Phase 3 Pivotal Trial For Epidiolex In Dravet Syndrome
Intra-Cellular Therapies, Inc. Presents The ITI-007 Clinical Development Program At The 15th International Congress On Schizophrenia Research
Ocata Therapeutics Successfully Completes Dosing In Phase 1/2 RPE Studies
BioTie Therapies Corp. Announces Start Of Patient Enrolment Into Phase IIa Clinical Study With BTT1023 In Primary Sclerosing Cholangitis
Capricor Therapeutics, Inc. Completes Enrollment Of Phase II Clinical Trial For Cenderitide To Treat Heart Failure
Peregrine Pharmaceuticals, Inc. (PPHM) Announces Promising Bavituximab Phase I Data Published In The Peer-Reviewed Journal Cancer Medicine In Advanced Metastatic Breast Cancer
Vaccinex, Inc. Provides An Update On Its VX15/2503 Phase 1 Clinical Trial In Multiple Sclerosis Patients
Hi-Tech Pharmaceuticals Announces Fastin Rapid Release Clinical Study Results
Trevi Therapeutics Announces Completion Of Enrollment In Pivotal Study Of Nalbuphine ER In Uremic Pruritus
Trial Shows Stem Cells Provide Long-Term Relief from Dangerous Crohn’s Side Effect, STEM CELLS Translational Medicine Reveals
RedHill Biopharma Ltd. (RDHL) Acquires Phase II First-in-Class Oral Small Molecule SK2 Inhibitor From Apogee Biotech
Nektar Therapeutics (NKTR) Release: MOVANTIK (Naloxegol) Tablets For The Treatment Of Opioid-Induced Constipation In Adult Patients With Chronic Non-Cancer Pain Launched In The US
Mylan (MYL) Launches Generic Exforge Tablets
Teva (TEVA) Expands Hypertension Line With Launch Of Generic Exforge Tablets In The United States
ANI Pharmaceuticals, Inc. Announces The Launch Of Propafenone Tablets
Argos Therapeutics, Inc. (ARGS) Reports Fourth Quarter And Year-End 2014 Financial Results
Emisphere Technologies, Inc. (EMIS) Reports Fourth Quarter And Full Year 2014 Financial Results
Achaogen (AKAO) Announces Webcast Providing Update On Development Plan For Plazomicin